Prescriber's Letter

46 - 60 of 60 Results

Sort Results:

Guideline: Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents (Updated 2012) February 2011

Article: Kapvay (clonidine extended-release) for attention deficit hyperactivity disorder (ADHD) in children February 2011

Article: Intuniv (in-TOO-niv), a new extended-release guanfacine for ADHD November 2009

Guideline: Diagnosis and Management of ADHD in Children and Adolescents (ICSI) (Updated 2012) November 2009

Guideline: Assessment and Treatment of Children and Adolescents with ADHD (AACAP) (2007) November 2009

Article: Stimulants work better than Strattera for treating ADHD in kids September 2008

Article: launch a "new and improved" formulation just before a drug gets generic competition September 2008

Chart: New Formulations of Old Drugs September 2008

Article: American Heart Assoc statement is raising a furor because it implies that ALL children on ADHD drugs need an ECG June 2008

Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008

Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008

Patient Education: Patient Handout to Go Along with Your MedGuide for ADHD Drugs June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008

Article: Know How New Stimulant and Nonstimulant ADHD Meds Compare